VitalConnect Closes $39 Million Series E Financing
The latest round of investment will go toward expanding the commercial team, scaling operations, and the development of new products
Read More
Financing
KKR Closes $4.0 Billion Health Care Strategic Growth Fund II
Successor Fund Reaffirms Firm’s Commitment to Investing in Innovative Health Care Growth Companies
Read More
Akura Medical Closes $25M Series A1 Financing
Company to accelerate development of its next-generation thrombectomy device for patients with venous thromboembolism
Read More
VESTECK Closes $5.95 Million Series A Financing
These Series A funds will be used to support the manufacturing of products, pre-clinical testing and completion of in human procedures, prior to our clinical study for FDA clearance
Read More
Olympus Launches Venture Capital Fund to Strengthen Medtech Leadership
Initial fund targets medical devices, digital solutions, and diagnostics
Read More
Aohua Endoscopy Lands on SSE STAR Market
Aohua Endoscopy (SHSE: 688212), a leading medical endoscope manufacturer, today landed on the SSE STAR Market (Shangai Stock Exchange Sci-Tech Innovation Board). The issue price is CNY 22.5
Read More
Beyeonics Surgical and Beyeonics Vision Raise $36 Million
Beyeonics Surgical and Beyeonics Vision are medical technology companies that aim to interface the systems in operating rooms using augmented reality, tracking and image processing/AI platforms
Read More
Cryosa Closes $21.5 Million Series B Funding
the fund to be used for continuing the development of its therapies for obstructive sleep apnea (OSA)
Read More
Francis Medical Closes $55 Million Series B Equity Financing
Francis Medical plans to use the Series B proceeds to fund the development of its proprietary prostate cancer treatment through FDA 510(k) approval, which includes a pivotal clinical study (VAPOR 2) for the management of prostate cancer, scheduled to begin enrollment in August 2022
Read More
Nectero Medical Completes $19.5 Million Series C Financing Led by Boston Scientific
Proceeds from new investors will fund in vivo and clinical development of innovative platform for aneurysmal disease, including Abdominal Aortic Aneurysms (AAA)
Read More